| Main study | Novel Therapies to Treat Resistant Focal Segmental Glomerulosclerosis: Phase II Clinical Trial |
|---|---|
| Contact name | Jochen Reiser |
| Contact phone | 305-243-2349 |
| Contact email | jreiser@med.miami.edu |
| Dua signed dt | Sept. 29, 2010, midnight |
| PI name | Jochen Reiser, Changli Wei |
| Site approved dt | April 15, 2010, midnight |
| Niddk signed dt | Oct. 18, 2010, midnight |